What is the share price of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) today?
The share price of BIOFILCHEM as on 13th March 2026 is ₹30.38. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?
The past returns of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share are- Past 1 week: -1.11%
- Past 1 month: -16.56%
- Past 3 months: -9.74%
- Past 6 months: -30.35%
- Past 1 year: -29.63%
- Past 3 years: -30.95%
- Past 5 years: -59.71%
What are the peers or stocks similar to Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM)?
The peers or stocks similar to Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) include:What is the market cap of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is ₹49.44 Cr as of 13th March 2026.What is the 52 week high and low of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?
The 52-week high of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is ₹57.19 and the 52-week low is ₹28.50.What is the PE and PB ratio of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) stock?
The P/E (price-to-earnings) ratio of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is 89.89. The P/B (price-to-book) ratio is 2.63.Which sector does Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) belong to?
Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) shares?
You can directly buy Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Biofil Chemicals and Pharmaceuticals Ltd
BIOFILCHEM Share Price
NSE₹30.380.82% (-0.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BIOFILCHEM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BIOFILCHEM Performance & Key Metrics
BIOFILCHEM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 18.04 | 2.63 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.98 | 5.67 | 0.59% |
BIOFILCHEM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BIOFILCHEM Company Profile
Biofil Chemicals and Pharmaceuticals Limited is engaged in pharmaceuticals and chemicals business. The Company is also engaged in manufacturing plastic products for the purpose of packing of pharmaceutical product and other plastic products.
SUNPHARMA
PE Ratio
39.55
39.55
1Y Return
7.02%
7.02%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
77.74
77.74
1Y Return
43.65%
43.65%
Buy Reco %
81.48
81.48
DRREDDY
PE Ratio
19.03
19.03
1Y Return
16.64%
16.64%
Buy Reco %
51.61
51.61
CIPLA
PE Ratio
20.14
20.14
1Y Return
10.07%
10.07%
Buy Reco %
54.84
54.84
LUPIN
PE Ratio
32.24
32.24
1Y Return
17.60%
17.60%
Buy Reco %
72.22
72.22
BIOFILCHEM Forecast
BIOFILCHEM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BIOFILCHEM
BIOFILCHEM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
BIOFILCHEM Income Statement
BIOFILCHEM Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.40 | 5.06 | 15.61 | 8.47 | 2.43 | 14.22 | 8.59 | 9.26 | 13.60 | 0.93 | ||||||||||
Operating & Other expenses | 17.13 | 4.84 | 15.24 | 8.14 | 2.29 | 13.89 | 8.24 | 6.43 | 13.43 | 0.76 | ||||||||||
EBITDA | 0.27 | 0.22 | 0.37 | 0.33 | 0.14 | 0.33 | 0.35 | 2.83 | 0.17 | 0.17 | ||||||||||
| Depreciation/Amortization | 0.11 | 0.11 | 0.08 | 0.10 | 0.10 | 0.10 | 0.08 | 0.07 | 0.07 | 0.07 | ||||||||||
| PBIT | 0.16 | 0.11 | 0.29 | 0.23 | 0.04 | 0.23 | 0.27 | 2.76 | 0.10 | 0.10 | ||||||||||
| Interest & Other Items | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | ||||||||||
| PBT | 0.15 | 0.11 | 0.27 | 0.22 | 0.03 | 0.22 | 0.26 | 2.75 | 0.10 | 0.10 | ||||||||||
| Taxes & Other Items | 0.03 | 0.02 | 0.03 | 0.06 | 0.01 | 0.06 | 0.06 | 0.35 | 0.03 | 0.03 | ||||||||||
| Net Income | 0.12 | 0.09 | 0.24 | 0.16 | 0.02 | 0.16 | 0.20 | 2.40 | 0.07 | 0.07 | ||||||||||
| EPS | 0.08 | 0.06 | 0.15 | 0.10 | 0.01 | 0.10 | 0.12 | 1.48 | 0.05 | 0.05 |
BIOFILCHEM Company Updates
BIOFILCHEM Stock Peers
BIOFILCHEM Past Performance & Peer Comparison
BIOFILCHEM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Biofil Chemicals and Pharmaceuticals Ltd | 89.89 | 2.63 | — |
| Sun Pharmaceutical Industries Ltd | 39.55 | 5.96 | 0.89% |
| Torrent Pharmaceuticals Ltd | 77.74 | 19.57 | 0.73% |
| Dr Reddy's Laboratories Ltd | 19.03 | 3.17 | 0.62% |
BIOFILCHEM Stock Price Comparison
Compare BIOFILCHEM with any stock or ETFCompare BIOFILCHEM with any stock or ETF
BIOFILCHEM
BIOFILCHEM Holdings
BIOFILCHEM Shareholdings
BIOFILCHEM Promoter Holdings Trend
BIOFILCHEM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BIOFILCHEM Institutional Holdings Trend
BIOFILCHEM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BIOFILCHEM Shareholding Pattern
BIOFILCHEM Shareholding Pattern
BIOFILCHEM Shareholding History
BIOFILCHEM Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing BIOFILCHEM stock
smallcases containing BIOFILCHEM stock
Looks like this stock is not in any smallcase yet.
BIOFILCHEM Events
BIOFILCHEM Events
BIOFILCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIOFILCHEM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BIOFILCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIOFILCHEM has not given any dividends in last 5 years
BIOFILCHEM Dividends
BIOFILCHEM Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBIOFILCHEM Stock News & Opinions
BIOFILCHEM Stock News & Opinions
Articles & Videos
Corporate
Biofil Chemicals & Pharmaceuticals to discuss results
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Biofil Chemicals & Pharmaceuticals Ltd leads gainers in 'B' group
Indo US Bio-Tech Ltd, United Foodbrands Ltd, Veer Global Infraconstruction Ltd and Mahalaxmi Fabric Mills Ltd are among the other gainers in the BSE's 'B' group today, 02 February 2026.Biofil Chemicals & Pharmaceuticals Ltd surged 17.88% to Rs 40.81 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 51521 shares were traded on the counter so far as against the average daily volumes of 16624 shares in the past one month. Indo US Bio-Tech Ltd spiked 13.24% to Rs 135.95. The stock was the second biggest gainer in 'B' group. On the BSE, 6910 shares were traded on the counter so far as against the average daily volumes of 5797 shares in the past one month. United Foodbrands Ltd soared 13.00% to Rs 245.1. The stock was the third biggest gainer in 'B' group. On the BSE, 1.89 lakh shares were traded on the counter so far as against the average daily volumes of 5029 shares in the past one month. Veer Global Infraconstruction Ltd advanced 12.15% to Rs 107.88. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1 shares were traded on the counter so far as against the average daily volumes of 1192 shares in the past one month. Mahalaxmi Fabric Mills Ltd jumped 11.01% to Rs 25.2. The stock was the fifth biggest gainer in 'B' group. On the BSE, 203 shares were traded on the counter so far as against the average daily volumes of 769 shares in the past one month. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit rises 300.00% in the September 2025 quarter
Net profit of Biofil Chemicals & Pharmaceuticals rose 300.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 461.83% to Rs 13.54 crore in the quarter ended September 2025 as against Rs 2.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales13.542.41 462 OPM %0.894.98 - PBDT0.180.13 38 PBT0.110.03 267 NP0.080.02 300 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals schedules board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to conduct AGM
Biofil Chemicals & Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit rises 1317.65% in the June 2025 quarter
Net profit of Biofil Chemicals & Pharmaceuticals rose 1317.65% to Rs 2.41 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales declined 23.82% to Rs 6.43 crore in the quarter ended June 2025 as against Rs 8.44 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales6.438.44 -24 OPM %0.163.67 - PBDT2.830.33 758 PBT2.760.23 1100 NP2.410.17 1318 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to convene board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit declines 20.00% in the March 2025 quarter
Net profit of Biofil Chemicals & Pharmaceuticals declined 20.00% to Rs 0.20 crore in the quarter ended March 2025 as against Rs 0.25 crore during the previous quarter ended March 2024. Sales declined 45.07% to Rs 8.35 crore in the quarter ended March 2025 as against Rs 15.20 crore during the previous quarter ended March 2024. For the full year,net profit declined 21.13% to Rs 0.56 crore in the year ended March 2025 as against Rs 0.71 crore during the previous year ended March 2024. Sales declined 16.58% to Rs 33.40 crore in the year ended March 2025 as against Rs 40.04 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales8.3515.20 -45 33.4040.04 -17 OPM %1.32-0.20 -2.542.05 - PBDT0.340.36 -6 1.121.27 -12 PBT0.260.28 -7 0.740.87 -15 NP0.200.25 -20 0.560.71 -21 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to hold board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit rises 77.78% in the December 2024 quarter
Net profit of Biofil Chemicals & Pharmaceuticals rose 77.78% to Rs 0.16 crore in the quarter ended December 2024 as against Rs 0.09 crore during the previous quarter ended December 2023. Sales rose 182.31% to Rs 14.20 crore in the quarter ended December 2024 as against Rs 5.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales14.205.03 182 OPM %2.183.78 - PBDT0.320.22 45 PBT0.220.11 100 NP0.160.09 78 Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 2.46%, vs industry avg of 9.88%
Over the last 5 years, market share stayed at 0.01%
Over the last 5 years, net income has grown at a yearly rate of -14.45%, vs industry avg of 19.69%